Serum and synovial fluid interleukin-17 concentrations in rheumatoid arthritis patients: Relation to disease activity, radiographic severity and power Doppler ultrasound

Kunwar, 2016, Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials, Rheumatol Int, 36, 1065, 10.1007/s00296-016-3480-9 Al-Saadany, 2016, Th-17 cells and serum IL-17 in rheumatoid arthritis patients: correlation with disease activity and severity, Egypt Rheumatol, 38, 1, 10.1016/j.ejr.2015.01.001 Hunter, 2017, Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014, Rheumatol Int, 37, 1551, 10.1007/s00296-017-3726-1 Chen, 2014, Association between severity of knee osteoarthritis and serum and synovial fluid interleukin 17 concentration, J Int Med Res, 42, 138, 10.1177/0300060513501751 Orita, 2011, Associations between proinflammatory cytokines in the synovial fluid and radiographic grading and pain related scores in 47consecutive patients with osteoarthritis of the knee, BMC Musculoskelet Disord, 12, 144, 10.1186/1471-2474-12-144 Hussein, 2016, Correlation between serum leptin, cytokines, cartilage degradation and functional impact in obese knee osteoarthritis patients, Egypt Rheumatol, 38, 117, 10.1016/j.ejr.2015.05.003 Al-Zifzaf, 2015, FoxP3+T regulatory cells in Rheumatoid arthritis and the imbalance of the Treg/TH17 cytokine axis, Egypt Rheumatol, 37, 7, 10.1016/j.ejr.2014.06.004 Jain, 2015, Increased plasma IL-17F levels in rheumatoid arthritis patients are responsive to methotrexate, anti-TNF, and T cell costimulatory modulation, Inflammation, 38, 180, 10.1007/s10753-014-0020-1 Miossec, 2009, Interleukin-17 and type 17 helper T cells, New Engl J Med, 361, 888, 10.1056/NEJMra0707449 Korayem, 2016, Relation between serum IL-17 level and risk of osteoporotic fracture in premenopausal rheumatoid arthritis patients: clinical, radiological and laboratory studies, Egypt Rheumatol, 38, 85, 10.1016/j.ejr.2015.06.006 Alsheikh, 2019, Serum interleukin-23 level in rheumatoid arthritis patients: relation to disease activity and severity, Egypt Rheumatol, 41, 99, 10.1016/j.ejr.2018.07.001 Shahrara, 2009, IL-17 induces monocyte migration in rheumatoid arthritis, J Immunol, 182, 3884, 10.4049/jimmunol.0802246 Aletaha, 2010, rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative study, Ann Rheum Dis, 69, 1580, 10.1136/ard.2010.138461 Altman, 1986, Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee, Arthritis Rheum, 29, 1039, 10.1002/art.1780290816 Prevoo, 1995, Modified disease activity scores that include twenty eight joints counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum, 38, 44, 10.1002/art.1780380107 Inoue, 2007, Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values, Ann Rheum Dis, 66, 407, 10.1136/ard.2006.054205 Larsen, 1995, How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies?, J Rheumatol, 22, 1974 Naredo, 2008, Validity, reproducibility, and responsiveness of a twelve-joint simplified power Doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis, Arthritis Rheum, 59, 515, 10.1002/art.23529 Calabresi, 2010, One year in review 2018: pathogenesis of rheumatoid arthritis, Clin Exp, 36, 175 Qu, 2019, Diagnostic values of serum IL-10 and IL-17 in rheumatoid arthritis and their correlation with serum 14-3-3η protein, Eur Rev Med Pharmacol Sci., 23, 1899 Dhaouadi, 2018, IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis, PLoS One, 13, e0194883, 10.1371/journal.pone.0194883 Elhewala, 2015, Interleukin-17 level in rheumatoid arthritis patients and its relation to disease activity: a clinical and ultrasound study, Egypt Rheumatol Rehabilitation, 42, 183, 10.4103/1110-161X.168164 Caetano-Lopes, 2014, Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression, Clin Rev Allergy Immunol, 47, 38, 10.1007/s12016-013-8366-y Khalifa, 2013, levels of interleukin 17, interleukin 23 and interleukin 27 in rheumatoid arthritis and osteoarthritis in Egyptian patients, Al-Azhar Med J, 42, 10.12816/0015728 Zrioual, 2008, IL-17RA and IL-17RC are essential for IL-17A-induced ELR CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood, J Immunol, 180, 655, 10.4049/jimmunol.180.1.655 Roşu, 2012, IL-17 patternsin synovium, serum and synovial fluid from treatment-naïve, early rheumatoid arthritis patients, Rom J Morphol Embryol, 53, 73 Kellner, 2013, Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential, Ther Adv Musculoskel Dis, 5, 141, 10.1177/1759720X13485328 Park, 2012, TWEAK promotes the production of interleukin-17 in rheumatoid arthritis, Cytokine, 60, 143, 10.1016/j.cyto.2012.06.285 Chabaud, 1999, Human IL-17: a T cell-derived cytokine produced by rheumatoid synovium, Arthritis Rheum, 42, 963, 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E Leipe, 2010, Role of Th17 cells in human autoimmune arthritis, Arthritis Rheum, 62, 2876, 10.1002/art.27622 Moran, 2009, Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies, Arthritis Res Ther, 11, R113, 10.1186/ar2772 Pavlovic, 2014, Serum levels of IL-17, IL-4, and INFγin Serbian patients with early rheumatoid arthritis, J Res Med Sci, 19, 18 SiloGi, 2016, The relationship of cytokines IL-13 and IL-17 with autoantibodies profile in early rheumatoid arthritis, Hindawi Publishing Corporation J Immunol Res Metawi, 2011, Serum and synovial fluid levels ofinterleukin-17 in correlation with disease activity in patients with RA, Clin Rheumatol, 30, 1201, 10.1007/s10067-011-1737-y Patel DN, King CA, Bailey SR, Holt JW, Venkatachalam K, Agrawal A, Valente AJ, Chandrasekar B, Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J BiolChem 2007;282:27229–38. Tukaj, 2010, Cytokines of the Th1 and Th2 type in sera of rheumatoid arthritis patients; correlations with anti-Hsp40 immune response and diagnostic markers, Acta Biochim Pol, 57, 327, 10.18388/abp.2010_2412 Ongkowijaya, 2010, Correlation of interleukin-17 with disease activity and hand joint damage in patients with rheumatoid arthritis, Indonesian J Rheumatol Yamada, 2008, Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis, Ann Rheum Dis, 67, 1299, 10.1136/ard.2007.080341 Kim J, Kang S, Kim J, Kwon G, Koo S. Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis. Ann Lab Med 2013;33:52–59. Elatar, 2017, Serum IL17 and IL4R RS1805010 genotypes: relationship with rheumatoid arthritis disease activity in Egyptian patients, Egypt J Biochem Mol Biol, 35, 27, 10.21608/ejb.2017.9692